AXIMRIS XR

Drug delivery systems comprising controlled timed-release and/or targeted-release pharmaceutical formulations, provided as integral components of pharmaceutical preparations; pharmaceutical preparations incorporating such drug delivery systems in the form of oral solid dosage units, namely tablets and capsules; all for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric and gastrointestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis, and rhinitis.